Centene Co. (NYSE:CNC) Shares Acquired by Andra AP fonden

Andra AP fonden increased its holdings in shares of Centene Co. (NYSE:CNC) by 7.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 388,300 shares of the company’s stock after purchasing an additional 27,900 shares during the quarter. Andra AP fonden owned approximately 0.08% of Centene worth $23,523,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in CNC. Capital Advisors Ltd. LLC lifted its stake in Centene by 75.3% during the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after purchasing an additional 177 shares during the last quarter. SRS Capital Advisors Inc. lifted its stake in Centene by 73.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock worth $38,000 after purchasing an additional 267 shares during the last quarter. Riverview Trust Co lifted its stake in Centene by 172.7% during the fourth quarter. Riverview Trust Co now owns 758 shares of the company’s stock worth $46,000 after purchasing an additional 480 shares during the last quarter. Private Trust Co. NA lifted its stake in Centene by 75.3% during the third quarter. Private Trust Co. NA now owns 773 shares of the company’s stock worth $58,000 after purchasing an additional 332 shares during the last quarter. Finally, True Wealth Design LLC purchased a new stake in Centene during the third quarter worth approximately $66,000. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Jefferies Financial Group cut Centene from a “hold” rating to an “underperform” rating and reduced their price objective for the company from $68.00 to $52.00 in a research note on Tuesday, December 10th. Barclays boosted their price objective on Centene from $91.00 to $93.00 and gave the company an “overweight” rating in a research note on Friday, December 13th. Argus cut Centene from a “buy” rating to a “hold” rating in a research note on Thursday, February 6th. StockNews.com cut Centene from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Finally, Truist Financial reduced their price objective on Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research note on Friday, December 13th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.92.

Centene Stock Performance

NYSE CNC opened at $59.43 on Friday. The business’s 50-day moving average price is $60.83 and its 200 day moving average price is $64.74. Centene Co. has a twelve month low of $55.03 and a twelve month high of $80.59. The company has a market capitalization of $29.48 billion, a PE ratio of 9.52, a price-to-earnings-growth ratio of 0.80 and a beta of 0.45. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70.

Centene (NYSE:CNC) last released its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The firm had revenue of $40.81 billion for the quarter, compared to the consensus estimate of $38.78 billion. During the same period in the prior year, the business posted $0.45 earnings per share. The firm’s revenue for the quarter was up 3.4% compared to the same quarter last year. On average, research analysts predict that Centene Co. will post 6.86 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Theodore R. Samuels II acquired 5,000 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were bought at an average cost of $58.86 per share, for a total transaction of $294,300.00. Following the acquisition, the director now directly owns 23,000 shares in the company, valued at $1,353,780. This trade represents a 27.78 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Thomas Greco acquired 17,000 shares of the business’s stock in a transaction dated Wednesday, December 18th. The stock was purchased at an average price of $59.75 per share, for a total transaction of $1,015,750.00. Following the completion of the acquisition, the director now owns 19,309 shares in the company, valued at approximately $1,153,712.75. This trade represents a 736.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have acquired 23,693 shares of company stock worth $1,409,954. 0.33% of the stock is owned by company insiders.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.